TN breast cancer patients harboring the BRCA1 mutations at the time of the diagnosis are younger, have smaller tumor size, and have significantly better recurrence-free and disease-specific survival than TN breast cancer patients with no mutations in the BRCA1 gene [7]-[10]. The gene discussed is BRCA1; the disease is breast carcinoma.